Bagri Puneet Kumar, Singhal Mukesh Kumar, Singh Daleep, Kapoor Akhil, Jakhar Shankar Lal, Sharma Neeti, Beniwal Surender, Kumar Harvindra Singh, Sharma Ajay, Bardia Megh Raj
Dept. of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner-334003, Rajasthan, India.
Medical Oncology section, Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner-334003, Rajasthan, India.
Iran J Cancer Prev. 2014 Winter;7(1):35-9.
This prospective study was conducted to evaluate and compare the efficacies of nasopharyngoscopy and CT scan in the diagnosis of local failure of external beam radiotherapy (EBRT) for nasopharyngeal carcinoma.
Total 52 patients of histopathologically proven nasopharyngeal carcinoma treated with external beam radiotherapy (EBRT), were included in this study. For every patient computed tomography (CT), nasopharyngoscopy and nasopharyngeal biopsies were performed 3 months after completion of EBRT.
Three months after completion of EBRT, 9 patients (17.3%) had evident disease on histological examination of biopsies. Nasopharyngoscopy showed 77.78% sensitivity, 93.03% specificity, 70% positive predictive value and 95.24% negative predictive value in diagnosing the residual/recurrence of tumor. There was statistically significant agreement between the endoscopic findings and the histological findings (Kappa reliability coefficient=0.562, p<0.01). On the other hand, CT scan showed a 55.56% sensitivity, 39.53% specificity, 16.13% positive predictive value and 80.95% negative predictive value in diagnosing the residual tumor/recurrence. There was no statistically significant agreement between the CT scan findings and the histological findings (Kappa reliability coefficient = 0.038, p>0.05).
Nasopharyngoscopy should be considered the primary follow-up tool after radiotherapy of nasopharyngeal carcinoma. CT scan should be reserved for patients with histological or any symptomatic indications. Routine postnasal biopsies are not required.
本前瞻性研究旨在评估和比较鼻咽镜检查与CT扫描在鼻咽癌外照射放疗(EBRT)局部失败诊断中的疗效。
本研究纳入了52例经组织病理学证实接受外照射放疗(EBRT)的鼻咽癌患者。对每位患者在EBRT完成后3个月进行计算机断层扫描(CT)、鼻咽镜检查和鼻咽活检。
EBRT完成后3个月,9例患者(17.3%)活检组织学检查显示有明显病变。鼻咽镜检查在诊断肿瘤残留/复发方面的敏感性为77.78%,特异性为93.03%,阳性预测值为70%,阴性预测值为95.24%。内镜检查结果与组织学检查结果之间存在统计学显著一致性(Kappa可靠性系数=0.562,p<0.01)。另一方面,CT扫描在诊断残留肿瘤/复发方面的敏感性为55.56%,特异性为39.53%,阳性预测值为16.13%,阴性预测值为80.95%。CT扫描结果与组织学检查结果之间不存在统计学显著一致性(Kappa可靠性系数=0.038,p>0.05)。
鼻咽癌放疗后应将鼻咽镜检查视为主要的随访工具。CT扫描应保留用于有组织学或任何症状指征的患者。无需常规进行鼻后活检。